Ikonomopoulou, M., López Mancheño, Y., Garrido Novelle, M., Martínez Uña, M., Gangoda, L., Martin, P., . . . Fernández Rojo, M. (2021). LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin target in Tasmanian devil facial tumor disease.
Citación estilo ChicagoIkonomopoulou, María, et al. LXR Stimulates a Metabolic Switch and Reveals Cholesterol Homeostasis As a Statin Target in Tasmanian Devil Facial Tumor Disease. 2021.
Cita MLAIkonomopoulou, María, et al. LXR Stimulates a Metabolic Switch and Reveals Cholesterol Homeostasis As a Statin Target in Tasmanian Devil Facial Tumor Disease. 2021.
Precaución: Estas citas no son 100% exactas.